The study on pharmacists [European Commission, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, Mapping and assessment of developments for sectoral professions under Directive 2005/36/EC – The profession of pharmacist, Publications Office of the European Union, 2022.] identified the following generally acknowledged scientific and technical advancements in training programmes in Member States and EFTA States that were not represented or not sufficiently represented in the current minimum training requirements set out in Directive 2005/36/EC: biopharmaceutical technology and biotechnology, genetics and pharmacogenomics, immunology, clinical pharmacy, pharmaceutical care, social pharmacy, epidemiology and pharmacoepidemiology, pharmacy practice, inter- and multidisciplinary collaboration, pathology and pathophysiology, health economics and pharmacoeconomics, information technology and digital technology.
Recital 12, Directive (EU) 2024/782
In forcesince 4 Mar 2024